食品补充剂的监管和药剂师在专业实践中的责任:审查
Cristina Ioana Niculaș1, Sonia Bianca Blaj2, Marius Călin Cherecheș3
1Medicine and Pharmacy Doctoral School, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
Pharmacy (Basel, Switzerland)
|February 20, 2026
概括
全球食品补充剂法规不一致,给药剂师带来了挑战. 这次审查强调缺乏标准化的法律,并没有发现与食品补充剂发行相关的不当行为案例,尽管存在消费者安全问题.
科学领域:
- 制药科学 制药科学
- 监管事务 监管事务
- 公共卫生 公共卫生
背景情况:
- 食品补充剂的全球法规显示出显著的差异,允许在一个国家禁止的产品在其他国家合法出售,在线销售加剧了这种情况.
- 由于没有统一的欧洲药品不当行为框架,这使药剂师责任的评估变得复杂,而药剂师责任则受各成员国法律的约束.
研究的目的:
- 绘制食品补充剂的全球监管格局.
- 检查药剂师的职业责任和有关食补充剂的滥用风险.
主要方法:
- 从2020年1月到2024年12月进行了一项全面的文献审查,分析了来自Scopus,PubMed,Embase和Web of Science的77项研究.
- 提取的数据按主题分为药剂师责任/不良做法,食品补充剂监管,消费者安全,健康声明和药剂师知识.
主要成果:
- 药房中的不当行为案例相对较少;没有发现的案件涉及药剂师在分发食品补充剂方面的责任.
- 食品补充剂监管存在重大不一致性,包括非标准化术语,不同的市场准入要求,以及产品成分和标签的不符合性.
- 观察到广泛的误导性广告和监管机构对健康主张的不遵守,以及药剂师对食品补充剂发行知识的挑战.
结论:
- 食品补充剂缺乏协调的全球监管框架,这就药剂师的职业角色和责任造成了模两可.
- 解决食品补充剂监管中的不一致性和提高药剂师知识对于确保消费者安全和专业责任至关重要.
相关概念视频
01:25Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
594
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
594
01:19Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
01:26Pharmaceutical Poisoning: Potential Scenarios
22
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22
01:26FDA Approved Drugs: Changes to Approved Drugs
289
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
289
01:24Dosage Regimen: Individualization
221
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
221